دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Inside This Issue
doi : 10.1016/S1936-8798(21)00975-4
Volume 14, Issue 12, 28 June 2021, Pages A12-A16
Principles of Intravascular Lithotripsy for Calcific Plaque Modification
Dean J.KereiakesMDaRenuVirmaniMDbJason Y.HokamaPhDcUdayIllindalaPhDcCarlosMena-HurtadoMDdAndrewHoldenMDeJonathan M.HillMDfSean P.LydenMDgZiad A.AliMD, DPhilh
doi : 10.1016/j.jcin.2021.03.036
Volume 14, Issue 12, 28 June 2021, Pages 1275-1292
A significant proportion of lesions treated with transcatheter interventions in the coronary and peripheral vascular beds exhibit moderate to severe calcific plaques known to portend lower procedural success rates, increased peri-procedural adverse events, and unfavorable clinical outcomes compared with noncalcific plaques. Adapted from lithotripsy technology used for treatment of ureterorenal calculi, intravascular lithotripsy (IVL) is a novel technique for the treatment of severely calcific plaque lesions that uses acoustic shockwaves in a balloon-based delivery system. Shockwaves induce calcium fractures, which facilitate stent expansion and luminal gain. In this review, the authors summarize the physics, preclinical and clinical data on IVL use in the coronary and peripheral vasculature, and future directions of IVL in transcatheter cardiovascular therapies.
Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention
Thomas A.MeijersMDaAdelAminianMDbMarleenvan WelyMDcKoenTeeuwenMD, PhDdThomasSchmitzMDeMaurits T.DirksenMD, PhDfSudhirRathoreMDgRené J.van der SchaafMD, PhDhPaulKnaapenMD, PhDiJosephDensMD, PhDjJuan F.IglesiasMDkPierfrancescoAgostoniMD, PhDlVincentRoolvinkMD, PhDaRenicus S.HermanidesMD, PhDaNielsvan RoyenMD, PhDcMaarten A.H.van LeeuwenMD, PhDa
doi : 10.1016/j.jcin.2021.03.041
Volume 14, Issue 12, 28 June 2021, Pages 1293-1303
The aim of this study was to investigate whether transradial (TR) percutaneous coronary intervention (PCI) is superior to transfemoral (TF) PCI in complex coronary lesions with large-bore guiding catheters with respect to clinically relevant access site–related bleeding or vascular complications.
Large-Bore Radial Access for Complex PCI: A Flash of COLOR With Some Shades of Gray?
MarcoValgimigliMD, PhDabAntonioLandiMDa
doi : 10.1016/j.jcin.2021.04.013
Volume 14, Issue 12, 28 June 2021, Pages 1304-1307
In-Stent CTO Percutaneous Coronary Intervention: Individual Patient Data Pooled Analysis of 4 Multicenter Registries
EvangeliaVemmouMDaAlexandre S.QuadrosMD, PhDbJoseph A.DensMD, PhDcNidal AbiRafehMDdPierfrancescoAgostoniMD, PhDeKhaldoonAlaswadMDfAlexandreAvranMD, MScgKarlyse C.BelliPhDbMauroCarlinoMDhJames W.ChoiMDiAhmedEl-GuindyMD, MScjFarouc A.JafferMD, PhDkDimitriKarmpaliotisMD, PhDlJaikirshan J.KhatriMDmDmitriiKhelimskiiMDnPaulKnaapenMD, PhDoAlessioLa MannaMDpOlegKrestyaninovMDnPabloLamelasMD, MScqSoledadOjedaMD, PhDrLucioPadillaMDqManuelPanMD, PhDrPedroPiccaro de OliveiraMD, PhDsStéphaneRinfretMD, SMtJames C.SprattMDuMasakiTanabeMDvSimonWalshMDwIliasNikolakopoulosMDaJuditKaracsonyiMD, PhDaBavana V.RanganBDS, MPHaEmmanouil S.BrilakisMD, PhDaLorenzoAzzaliniMD, PhD, MScx
doi : 10.1016/j.jcin.2021.04.003
Volume 14, Issue 12, 28 June 2021, Pages 1308-1319
The authors sought to examine the outcomes of percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) chronic total occlusions (CTOs).
In-Stent CTO PCI: An Expanding Horizon?
ZiyadGhazzalMDFadiSawayaMD
doi : 10.1016/j.jcin.2021.04.017
Volume 14, Issue 12, 28 June 2021, Pages 1320-1322
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial Infarction
Rosanne F.VogelMDaRonakDelewiMD, PhDbDominick J.AngiolilloMD, PhDcJeroen M.WilschutMDdMiguel E.LemmertMD, PhDdeRobertoDilettiMD, PhDdRiavan VlietfNancy W.P.L.van der WaardenMScgRutger-JanNuisMD, PhDdValeriaParadiesMDfDimitriosAlexopoulosMD, PhDhFelixZijlstraMD, PhDdGillesMontalescotMD, PhDiMitchell W.KrucoffMD, PhDjNicolas M.van MieghemMD, PhDdPieter C.SmitsMD, PhDfGeorgios J.VlachojannisMD, PhDaf
doi : 10.1016/j.jcin.2021.04.022
Volume 14, Issue 12, 28 June 2021, Pages 1323-1333
This study sought to compare the pharmacodynamic effects of pre-hospitally administered P2Y12 inhibitor prasugrel in crushed versus integral tablet formulation in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI).
Crushed Prasugrel Improves Pharmacodynamics But Little Else: Where Are the Missing Pieces??
ArkaChatterjeeMDKristinaSkinnerDO
doi : 10.1016/j.jcin.2021.05.001
Volume 14, Issue 12, 28 June 2021, Pages 1334-1336
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions: Patient-Level Pooled Analysis of the Disrupt CAD Studies
Dean J.KereiakesMDaCarloDi MarioMDbRobert F.RileyMDaJeanFajadetMDcRichard A.ShlofmitzMDdShigeruSaitoMDeZiad A.AliMD, DPhildfAndrew J.KleinMDgMatthew J.PriceMDhJonathan M.HillMDiGregg W.StoneMDj
doi : 10.1016/j.jcin.2021.04.015
Volume 14, Issue 12, 28 June 2021, Pages 1337-1348
The aim of this pooled analysis was to assess the cumulative safety and effectiveness of coronary intravascular lithotripsy (IVL).
Absorbing the Aftershocks of a New Device for Coronary Calcification?
Ajay J.KirtaneMDMatthew T.FinnMD
doi : 10.1016/j.jcin.2021.05.008
Volume 14, Issue 12, 28 June 2021, Pages 1349-1351
Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Randomized Disrupt PAD III Trial
GunnarTepeMDaMarianneBrodmannMDbMartinWernerMDcWilliamBachinskyMDdAndrewHoldenMDeThomasZellerMDfSarangMangalmurtiMDgClausNolte-ErnstingMDhBarryBertoletMDiDierkScheinertMD, PhDjWilliam A.GrayMDkDisrupt PAD III Investigators
doi : 10.1016/j.jcin.2021.04.010
Volume 14, Issue 12, 28 June 2021, Pages 1352-1361
The study sought to compare short-term outcomes in patients with femoropopliteal artery calcification receiving vessel preparation with intravascular lithotripsy (IVL) or percutaneous transluminal angioplasty (PTA) prior to drug-coated balloon (DCB) for symptomatic peripheral artery disease.
Making Lemonade Out of the Lemons of Lesion Preparation?
Christopher J.WhiteMDabJoshua A.BeckmanMDc
doi : 10.1016/j.jcin.2021.04.025
Volume 14, Issue 12, 28 June 2021, Pages 1362-1363
Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism: The SUNSET sPE Trial
Efthymios D.AvgerinosMDaWissamJaberMDbJoanLacomisMDcKyleMarkelMDaMichaelMcDanielMDbBelinda N.Rivera-LebronMDdCharles B.RossMDeJacobSechristMDcCatalinTomaMDfRabihChaerMDa
doi : 10.1016/j.jcin.2021.04.049
Volume 14, Issue 12, 28 June 2021, Pages 1364-1373
The aim of this trial was to determine whether ultrasound-assisted thrombolysis (USAT) is superior to standard catheter-directed thrombolysis (SCDT) in pulmonary arterial thrombus reduction for patients with submassive pulmonary embolism (sPE).
Is it Time to Sunset Ultrasound-Assisted Catheter-Directed Thrombolysis for Submassive PE??
Akhilesh K.SistaMD
doi : 10.1016/j.jcin.2021.05.020
Volume 14, Issue 12, 28 June 2021, Pages 1374-1375
OCT Guidance for Detection and Treatment of Free-Floating Struts Following Ostial LAD Stenting
DejanMilasinovicMDabMilojeTomasevicMD, PhDacVladanVukcevicMD, PhDabGoranStankovicMD, PhDab
doi : 10.1016/j.jcin.2021.03.016
Volume 14, Issue 12, 28 June 2021, Pages 1376-1377
Dynamic Nature of Nodular Calcification in Cardiac Allograft Vasculopathy
YujiKiyoseaTatsuyaShirakiMDbIsamuMizoteMD, PhDbDaisukeNakamuraMDbYasumasaTsukamotoMD, PhDbKensukeYokoiMDbHidetakaKiokaMD, PhDbTomohitoOhtaniMD, PhDbShungoHikosoMD, PhDbShigeruMinamiPhDaYasushiSakataMD, PhDb
doi : 10.1016/j.jcin.2021.03.042
Volume 14, Issue 12, 28 June 2021, Pages 1378-1380
Alcohol Septal Ablation for Hypertrophic Cardiomyopathy Through an Anomalous Septal Perforator Off the Right Cusp
Madeline K.MahowaldMDMichel T.CorbanMDMackram F.EleidMDRick A.NishimuraMD
doi : 10.1016/j.jcin.2021.04.018
Volume 14, Issue 12, 28 June 2021, Pages e129-e130
Percutaneous Retrieval of an Inferior Vena Cava Filter Penetrating Into the Duodenum
HiroyukiGiboMDaShotaSaitoMDaJiroKoyaMDaYutaroYasuiMDaYusukeTokudaMD, PhDaKazuyaSugitatsuMDaYasuhiroMakitaMDaKazuharuSuzukiMDbShuichiMiyamotoMDbMorioShodaMD, PhDcd
doi : 10.1016/j.jcin.2021.03.044
Volume 14, Issue 12, 28 June 2021, Pages e131-e133
Carotid-Esophageal Fistula Secondary to Laryngeal Carcinoma: Successful Endovascular Exclusion
FélixDamas de los SantosMDaJulio I.Farjat PasosMDaKathia E.Estrada LopezMDaRam?n J.Cue CarpioMDbEduardo A.AriasMDa
doi : 10.1016/j.jcin.2021.03.017
Volume 14, Issue 12, 28 June 2021, Pages e135-e138
Dual-Guide Triple-Kiss Technique for Left Main Trifurcation
SripalBangaloreMD, MHAAhmadAlkhalilMDFrederickFeitMDNormaKellerMDCraigThompsonMD
doi : 10.1016/j.jcin.2021.03.067
Volume 14, Issue 12, 28 June 2021, Pages e139-e141
Modification of the Single-Access High-Risk PCI Technique for 3 Catheters: 9 + 4 + 6 = 14
Alexandra E.TengMDaJosephYangMDabJeffrey M.ZimmetMD, PhDabKendrick A.ShunkMD, PhDab
doi : 10.1016/j.jcin.2021.03.068
Volume 14, Issue 12, 28 June 2021, Pages e143-e145
Uninterrupted Oral Anticoagulation Percutaneous Coronary Intervention: A Safe Strategy
Juan G.C?rdoba-SorianoMDJuan JoséPortero-PortazMDArsenioGallardo-L?pezMDAntonioGutiérrez-D?ezMDDrissMelehiMD, PhDJes?sJiménez-MazuecosMD
doi : 10.1016/j.jcin.2021.04.027
Volume 14, Issue 12, 28 June 2021, Pages 1381-1382
Reply: Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
DimitriosVenetsanosMD, PhDMikolajSkibniewskiMDJoakimAlfredssonMD, PhD
doi : 10.1016/j.jcin.2021.05.009
Volume 14, Issue 12, 28 June 2021, Page 1382
Can Cocaine Use Cause Myocardial Infarction?
JaytinGuptaMSHector M.Garcia-GarciaMD, PhD
doi : 10.1016/j.jcin.2021.04.029
Volume 14, Issue 12, 28 June 2021, Page 1383
Reply: Cocaine-Associated Myocardial Infarction: Association Versus Causation
ShilpkumarAroraMPH, MDRahulJaswaneyMDMehdi H.ShishehborDO, MPH, PhD
doi : 10.1016/j.jcin.2021.05.003
Volume 14, Issue 12, 28 June 2021, Pages 1383-1384
Aspiration Thrombectomy in Intermediate-High Risk Pulmonary Embolism Patients: More Work Ahead
MarcoZuinMDGianlucaRigatelliMD, PhDGiovanniZulianiMD, PhDLorisRonconMD
doi : 10.1016/j.jcin.2021.04.039
Volume 14, Issue 12, 28 June 2021, Pages 1384-1385
Reply: Aspiration Thrombectomy in Intermediate-High Risk Pulmonary Embolism Patients: More Work Ahead
Akhilesh K.SistaMDJames M.HorowitzMDVictor F.TapsonMDJames F.BenenatiMD
doi : 10.1016/j.jcin.2021.05.018
Volume 14, Issue 12, 28 June 2021, Pages 1385-1386
Comparing Baseline Data From Registries With Trials: Evidence From the CathPCI Registry and DAPT Study
Neel M.ButalaMD, MBAKamil F.FaridiMDEric A.SecemskyMD, MScYangSongMSJepthaCurtisMDC. MichaelGibsonMD, MSRalphBrindisMD, MPHChangyuShenPhDRobert W.YehMD, MSc
doi : 10.1016/j.jcin.2021.03.065
Volume 14, Issue 12, 28 June 2021, Pages 1386-1388
A Meta-Analysis of Recent Trials Comparing Revascularization With Medical Therapy Alone in Patients With Chronic Coronary Syndrome
William F.FearonMD†CarlosColletMD, PhD†BrunoRoza da CostaPhDTakuyaMizukamiMD, PhDEmanueleBarbatoMD, PhDPim A.L.ToninoMD, PhDNico H.J.PijlsMD, PhDPeterJüniMD‡BernardDe BruyneMD, PhD‡
doi : 10.1016/j.jcin.2021.04.021
Volume 14, Issue 12, 28 June 2021, Pages 1388-1390
Sex-Related Differences in Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
JosefVeselkaMD, PhDLotharFaberMD, PhDMaxLiebregtsMD, PhDRobertCooperMBChB, MRCPMaksimKashtanovMD, PhDPeter RiisHansenMD, DMSc, PhDJiriBonaventuraMDEvaPolakovaMDEvaHansvenclovaHenningBundgaardMD, DMScJurriënten BergMD, PhDMorten KvistholmJensenMD, PhD
doi : 10.1016/j.jcin.2021.03.066
Volume 14, Issue 12, 28 June 2021, Pages 1390-1392
